This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of pregnant individuals who have OUD and their babies.
Dashboard: Filter Bricks
Main page content
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep23-02-01-002.jpg?itok=Te_nXqI2)
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep23-02-00-005.png?itok=OJvi5xUL)
The Advisory outlines the principles and components of low barrier care, and how low barrier care may be leveraged to overcome substantial gaps in access, while also engaging individuals in treatment.
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep23-06-00-001.jpg?itok=GKQ7uAty)
This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep23-06-05-007.jpg?itok=1cCFjPNP)
This advisory discusses the epidemiology of the mental health symptoms and conditions of Long COVID, provides evidence-based resources for the treatment of those conditions, and offers possible resources.
![Advisory: Cannabidiol (CBD) Potential Harm, Side Effects, and Unknowns](/sites/default/files/styles/product_thumbnail_dashboard/public/pep22-06-04-003.png?itok=pJrQIhAy)
This advisory introduces readers to Cannabidiol (CBD), how it is derived, how it differs from THC and other cannabinoids, the risks and harms of CBD use, and common misconceptions given its broad availability.
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep21-06-01-003.png?itok=8Lbgq4nk)
This Advisory reviews the evidence on prescription stimulant misuse among youth and young adults. It establishes prescription stimulant misuse as a public health problem, identifies associated risk and protective factors, and provides programs and action steps for stakeholders to prevent misuse.
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep21-05-03-001.png?itok=jGwIqS6y)
This Advisory is an update to the SMA10-4591, Vol. 9 Issue 2, published in 2010. The advisory summarizes key elements of Traumatic Brain Injury (TBI), and describes its relevance to behavioral health, including recommendations for behavioral health professionals.
![Advisory: Clinical Issues in Intensive Outpatient Treatment for Substance Use Disorders (based on TIP 47)](/sites/default/files/styles/product_thumbnail_dashboard/public/PEP20-02-01-021.jpg?itok=EtUbDd-d)
This Advisory, TIP 47, Substance Abuse: Clinical Issues in Intensive Outpatient Treatment, provides an overview of intensive outpatient (IOP) treatment. It discusses typical program goals; outlines key features that improve engagement, retention, and outcomes; and provides additional resources on this critical topic.
![Opioid Therapy in Patients With Chronic Noncancer Pain Who Are in Recovery From Substance Use Disorders](/sites/default/files/styles/product_thumbnail_dashboard/public/PEP20-02-01-022.jpg?itok=hqavuo0e)
This Advisory, based on Treatment Improvement Protocol (TIP) 54, Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders, is for primary care providers who treat or are likely to treat adult patients with or in recovery from substance use disorders (SUDs) who present with chronic pain. It addresses screening and assessment tools, nonpharmacologic and nonopioid treatment for chronic pain, and the role of opioid therapy in people with chronic noncancer pain and SUDs.
![Advisory: Competencies for Supervision in Substance Use Disorder Treatment (based on TAP 21-A)](/sites/default/files/styles/product_thumbnail_dashboard/public/PEP20-02-01-018.jpg?itok=KWW6SMTS)
This Advisory is based on Technical Assistance Publication (TAP) 21-A, Competencies for Substance Abuse Treatment Clinical Supervisors. It identifies foundational knowledge and concepts essential for supervisory proficiency, roles and skills expected of clinical supervisors, the purpose and context of competencies for supervision in substance use disorder (SUD) treatment programs, and dissemination and implementation of these competencies.
Displaying 1 - 10 out of 31